Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies ; volume:15 ; number:1 ; day:9 ; month:2 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (9.2.2017), 1-11, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
William, Doreen
- Beteiligte Personen und Organisationen
-
Mullins, Christina Susanne
Schneider, Björn
Orthmann, Andrea
Lamp, Nora
Krohn, Mathias
Hoffmann, Annika
Classen, Carl-Friedrich
Linnebacher, Michael
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1128-5
- URN
-
urn:nbn:de:1111-2017030512575
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- William, Doreen
- Mullins, Christina Susanne
- Schneider, Björn
- Orthmann, Andrea
- Lamp, Nora
- Krohn, Mathias
- Hoffmann, Annika
- Classen, Carl-Friedrich
- Linnebacher, Michael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Patient-derived xenografts as preclinical neuroblastoma models
Mifepristone improves chemo-radiation response in glioblastoma xenografts
Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts
Patient-derived xenografts: a relevant preclinical model for drug development
Optimized scaling of translational factors in oncology: from xenografts to RECIST
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion
Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities
Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy
Patient-derived xenografts as preclinical neuroblastoma models
Mifepristone improves chemo-radiation response in glioblastoma xenografts
Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts
Patient-derived xenografts: a relevant preclinical model for drug development
Optimized scaling of translational factors in oncology: from xenografts to RECIST
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion
Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities
Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma
Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy
Patient-derived xenografts as preclinical neuroblastoma models
Mifepristone improves chemo-radiation response in glioblastoma xenografts
Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts
Patient-derived xenografts: a relevant preclinical model for drug development
Optimized scaling of translational factors in oncology: from xenografts to RECIST
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion
Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities
Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme
Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma